BDBM730229 US20250108139, Compound DB-13

SMILES O=COCN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)NCC(=O)N2CN(C(=O)CNC(=O)CCC(=O)C[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)CN(C(=O)CNC(=O)CCC(=O)N[C@H]3CC[C@H](C(=O)N[C@@H](Cc4ccc5ccccc5c4)C(=O)NCCCCC(NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)CC3)C2)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 730229   

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730229(US20250108139, Compound DB-13)
Affinity DataKd: <100nMAssay Description:Table 5: The affinity of DB compounds to PSMA protein was tested using the Biacore 8K (Cytiva) instrument to detect ligand binding to PSMA protein (S...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details
US Patent